Newronika’s AlphaDBS System Earns CE Mark in Europe

Newronika’s AlphaDBS System Earns CE Mark in Europe

288043

Newronika’s AlphaDBS System Earns CE Mark in Europe

Newronika‘s AlphaDBS, an innovative deep brain stimulation (DBS) system being evaluated in patients with Parkinson’s disease, has received CE Mark approval in Europe. The CE Mark is a seal of approval issued by the European Commission that means products have been assessed to meet pre-established safety, health, and environmental protection requirements. CE Marking also supports fair competition by holding all companies accountable to the same rules. DBS is an established treatment for people with Parkinson’s…

You must be logged in to read/download the full post.